newsfilter
← Latest News
PR Newswire·

Soliton Announces Initiation of Second Animal Study for Potential RAP Treatment of Liver Fibrosis

Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary aesthetic platform technology,...